These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36578570)

  • 1. Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid.
    Li M; Chen Y; Wang L; Lu C; Chen P; Jin Y; Li J; Gao F; Shang Z; Lin W
    Front Microbiol; 2022; 13():1045291. PubMed ID: 36578570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations into the Antibacterial Mechanism of Action of Viridicatumtoxins.
    Li W; Li L; Zhang C; Cai Y; Gao Q; Wang F; Cao Y; Lin J; Li J; Shang Z; Lin W
    ACS Infect Dis; 2020 Jul; 6(7):1759-1769. PubMed ID: 32437130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional Analysis of the Effects of Gambogic Acid and Neogambogic Acid on Methicillin-Resistant
    Hua X; Jia Y; Yang Q; Zhang W; Dong Z; Liu S
    Front Pharmacol; 2019; 10():986. PubMed ID: 31572177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthranilic Acid Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for Bacterial Cell Wall Biosynthesis.
    Jukič M; Rožman K; Sova M; Barreteau H; Gobec S
    Front Microbiol; 2018; 9():3322. PubMed ID: 30692977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis.
    Guo RT; Ko TP; Chen AP; Kuo CJ; Wang AH; Liang PH
    J Biol Chem; 2005 May; 280(21):20762-74. PubMed ID: 15788389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and structural characterization of an allosteric inhibitor of bacterial cis-prenyltransferase.
    Danley DE; Baima ET; Mansour M; Fennell KF; Chrunyk BA; Mueller JP; Liu S; Qiu X
    Protein Sci; 2015 Jan; 24(1):20-6. PubMed ID: 25287857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-coated liposomes for enhanced
    Lv H; Miao M; Wu Z; Huang C; Tang X; Yan R
    J Liposome Res; 2024 May; ():1-12. PubMed ID: 38733152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biophysical investigation of the mode of inhibition of tetramic acids, the allosteric inhibitors of undecaprenyl pyrophosphate synthase.
    Lee LV; Granda B; Dean K; Tao J; Liu E; Zhang R; Peukert S; Wattanasin S; Xie X; Ryder NS; Tommasi R; Deng G
    Biochemistry; 2010 Jun; 49(25):5366-76. PubMed ID: 20476728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Mechanism of Action of Ginkgolic Acid (15:1) against Gram-Positive Bacteria Involves Cross Talk with Iron Homeostasis.
    Wen Z; Zhao Y; Gong Z; Tang Y; Xiong Y; Chen J; Chen C; Zhang Y; Liu S; Zheng J; Li D; Deng Q; Yu Z
    Microbiol Spectr; 2022 Feb; 10(1):e0099121. PubMed ID: 35019708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of triton concentration on the activity of undecaprenyl pyrophosphate synthase inhibitors.
    Li H; Huang J; Jiang X; Seefeld M; McQueney M; Macarron R
    J Biomol Screen; 2003 Dec; 8(6):712-5. PubMed ID: 14711397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substrate and product specificities of cis-type undecaprenyl pyrophosphate synthase.
    Chen AP; Chang SY; Lin YC; Sun YS; Chen CT; Wang AH; Liang PH
    Biochem J; 2005 Feb; 386(Pt 1):169-76. PubMed ID: 15447632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants.
    Chen YH; Chen AP; Chen CT; Wang AH; Liang PH
    J Biol Chem; 2002 Mar; 277(9):7369-76. PubMed ID: 11744728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Prenyltransferase Inhibitors with
    Song J; Malwal SR; Baig N; Schurig-Briccio LA; Gao Z; Vaidya GS; Yang K; Abutaleb NS; Seleem MN; Gennis RB; Pogorelov TV; Oldfield E; Feng X
    ACS Infect Dis; 2020 Nov; 6(11):2979-2993. PubMed ID: 33085463
    [No Abstract]   [Full Text] [Related]  

  • 14. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
    Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
    Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and application of a fluorescent substrate analogue to study ligand interactions for undecaprenyl pyrophosphate synthase.
    Chen AP; Chen YH; Liu HP; Li YC; Chen CT; Liang PH
    J Am Chem Soc; 2002 Dec; 124(51):15217-24. PubMed ID: 12487597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Characterization of a Class of Pyrazole Inhibitors of Bacterial Undecaprenyl Pyrophosphate Synthase.
    Concha N; Huang J; Bai X; Benowitz A; Brady P; Grady LC; Kryn LH; Holmes D; Ingraham K; Jin Q; Pothier Kaushansky L; McCloskey L; Messer JA; O'Keefe H; Patel A; Satz AL; Sinnamon RH; Schneck J; Skinner SR; Summerfield J; Taylor A; Taylor JD; Evindar G; Stavenger RA
    J Med Chem; 2016 Aug; 59(15):7299-304. PubMed ID: 27379833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Insights into the Inhibition of Undecaprenyl Pyrophosphate Synthase from Gram-Positive Bacteria.
    Workman SD; Day J; Farha MA; El Zahed SS; Bon C; Brown ED; Organ MG; Strynadka NCJ
    J Med Chem; 2021 Sep; 64(18):13540-13550. PubMed ID: 34473495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species differences in alternative substrate utilization by the antibacterial target undecaprenyl pyrophosphate synthase.
    Dodbele S; Martinez CD; Troutman JM
    Biochemistry; 2014 Aug; 53(30):5042-50. PubMed ID: 25020247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of site-directed mutagenesis of the conserved aspartate and glutamate on E. coli undecaprenyl pyrophosphate synthase catalysis.
    Pan JJ; Yang LW; Liang PH
    Biochemistry; 2000 Nov; 39(45):13856-61. PubMed ID: 11076526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in the Development of Undecaprenyl Pyrophosphate Synthase Inhibitors as Potential Antibacterials.
    Jukic M; Rozman K; Gobec S
    Curr Med Chem; 2016; 23(5):464-82. PubMed ID: 26718796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.